CD4 + CD25 + Foxp3 + Regulatory T Cells Contribute in Liver Fibrosis Improvement with Interferon Alpha

  • PDF / 596,643 Bytes
  • 9 Pages / 595.276 x 790.866 pts Page_size
  • 8 Downloads / 163 Views

DOWNLOAD

REPORT


CD4+CD25+Foxp3+ Regulatory T Cells Contribute in Liver Fibrosis Improvement with Interferon Alpha L. Feng,1,2 H. Kang,2,4 L. N. Liu,2 and Y. M. Cao3

Abstract—The aim of this study is to investigate the optimal dose, treatment time, and possible immunologic mechanisms of interferon alpha (IFN-α) in the treatment of liver fibrosis. Mice were injected intraperitoneally with 10 % carbon tetrachloride to induce liver fibrosis, except in the normal control group. The experimental mice were randomly divided into four groups: physiological saline group, 20 U/gb wt IFN-α group, 40 U/gb wt IFN-α group, and 60 U/gb wt IFN-α group. After 3 and 6 weeks, type I collagen was detected in liver by hematoxylin and eosin (HE) stain, Masson’s trichrome stain, and immunohistochemical staining. The number of CD8+ T cells, the number of CD4+CD25+Foxp3+ Tregs and the activation of CD4+ T cells were detected in liver and spleen. Beneficial effects were observed in the 40 U/gb wt IFN-α group by pathological analysis. The number of CD8+ T cells in the liver was significantly lower in mice receiving middle-dose IFN-α therapy as compared to mice receiving physiological saline (P